BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 24418862)

  • 1. Peripheral T-cell lymphomas with cytotoxic phenotype in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Boyer DF; Lindeman NI; Harris NL; Ferry JA
    Am J Surg Pathol; 2014 Feb; 38(2):279-88. PubMed ID: 24418862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perforin and granzyme expression in cytotoxic T-cell lymphomas.
    Yamashita Y; Yatabe Y; Tsuzuki T; Nakayama A; Hasegawa Y; Kojima H; Nagasawa T; Mori N
    Mod Pathol; 1998 Apr; 11(4):313-23. PubMed ID: 9578080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral T cell and natural killer (NK) T cell lymphomas: a clinicopathological study from a single Australian centre.
    McKelvie PA; Thompson PA; Tam CS
    Histopathology; 2012 Aug; 61(2):212-23. PubMed ID: 22716228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angioimmunoblastic T-Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Novel Form of Composite Lymphoma Potentially Mimicking Richter Syndrome.
    Trimech M; Letourneau A; Missiaglia E; De Prijck B; Nagy-Hulliger M; Somja J; Vivario M; Gaulard P; Lambert F; Bisig B; de Leval L
    Am J Surg Pathol; 2021 Jun; 45(6):773-786. PubMed ID: 33739791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrum.
    Falini B; Bigerna B; Fizzotti M; Pulford K; Pileri SA; Delsol G; Carbone A; Paulli M; Magrini U; Menestrina F; Giardini R; Pilotti S; Mezzelani A; Ugolini B; Billi M; Pucciarini A; Pacini R; Pelicci PG; Flenghi L
    Am J Pathol; 1998 Sep; 153(3):875-86. PubMed ID: 9736036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric analysis of lymphoid enhancer-binding factor 1 in diagnosis of chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Amador-Ortiz C; Goolsby CL; Peterson LC; Wolniak KL; McLaughlin JL; Gao J; Chen YH
    Am J Clin Pathol; 2015 Feb; 143(2):214-22. PubMed ID: 25596247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Composite peripheral T-cell lymphoma not otherwise specified, and B-cell small lymphocytic lymphoma presenting with hemophagocytic lymphohistiocytosis.
    Alomari A; Hui P; Xu M
    Int J Surg Pathol; 2013 Jun; 21(3):303-8. PubMed ID: 23129836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary cutaneous lymphomas in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): A series of 12 cases.
    Liu YA; Finn AJ; Subtil A
    J Cutan Pathol; 2021 May; 48(5):617-624. PubMed ID: 33415780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALK-positive anaplastic large cell lymphoma in a patient with chronic lymphocytic leukemia.
    Liu T; He M; Carlson DL; Hedvat C; Teruya-Feldstein J
    Int J Surg Pathol; 2010 Oct; 18(5):424-8. PubMed ID: 18794171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
    Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
    Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project.
    Savage KJ; Harris NL; Vose JM; Ullrich F; Jaffe ES; Connors JM; Rimsza L; Pileri SA; Chhanabhai M; Gascoyne RD; Armitage JO; Weisenburger DD;
    Blood; 2008 Jun; 111(12):5496-504. PubMed ID: 18385450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD23 expression in transformed small lymphocytic lymphomas/chronic lymphocytic leukemias and blastic transformations of mantle cell lymphoma.
    Dunphy CH; Wheaton SE; Perkins SL
    Mod Pathol; 1997 Aug; 10(8):818-22. PubMed ID: 9267825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXP3-positive T-cell lymphomas in non-HTLV1 carriers include ALK-negative anaplastic large cell lymphoma: expanding the spectrum of T-cell lymphomas with regulatory phenotype.
    Ferreira CR; Zhao S; Sahoo MK; Pinsky B; Weber J; Lage LAPC; Pereira J; Zerbini MCN; Natkunam Y
    Hum Pathol; 2018 Oct; 80():138-144. PubMed ID: 29898383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous diagnosis of hairy cell leukemia and chronic lymphocytic leukemia/small lymphocytic lymphoma: a frequent association?
    Giné E; Bosch F; Villamor N; Rozman M; Colomer D; López-Guillermo A; Campo E; Montserrat E
    Leukemia; 2002 Aug; 16(8):1454-9. PubMed ID: 12145685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic protein expression in natural killer cell lymphomas and in alpha beta and gamma delta peripheral T-cell lymphomas.
    Boulland ML; Kanavaros P; Wechsler J; Casiraghi O; Gaulard P
    J Pathol; 1997 Dec; 183(4):432-9. PubMed ID: 9496260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T- and null-cell type and Hodgkin's disease: evidence for distinct cellular origin.
    Krenacs L; Wellmann A; Sorbara L; Himmelmann AW; Bagdi E; Jaffe ES; Raffeld M
    Blood; 1997 Feb; 89(3):980-9. PubMed ID: 9028330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic profiling of peripheral T-cell lymphoma, unspecified, and anaplastic large T-cell lymphoma delineates novel recurrent chromosomal alterations.
    Zettl A; Rüdiger T; Konrad MA; Chott A; Simonitsch-Klupp I; Sonnen R; Müller-Hermelink HK; Ott G
    Am J Pathol; 2004 May; 164(5):1837-48. PubMed ID: 15111330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal T-cell populations and increased risk for cytotoxic T-cell lymphomas in B-CLL patients: clinicopathologic observations and molecular analysis.
    Martinez A; Pittaluga S; Villamor N; Colomer D; Rozman M; Raffeld M; Montserrat E; Campo E; Jaffe ES
    Am J Surg Pathol; 2004 Jul; 28(7):849-58. PubMed ID: 15223953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cytotoxic phenotype does not predict clinical outcome in anaplastic large cell lymphomas.
    Dukers DF; ten Berge RL; Oudejans JJ; Pulford K; Hayes D; Miseré JF; Ossenkoppele GJ; Jaspars LH; Willemze R; Meijer CJ
    J Clin Pathol; 1999 Feb; 52(2):129-36. PubMed ID: 10396241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uniform expression of cytotoxic molecules in anaplastic large cell lymphoma of null/T cell phenotype and in cell lines derived from anaplastic large cell lymphoma.
    Foss HD; Demel G; Anagnostopoulos I; Araujo I; Hummel M; Stein H
    Pathobiology; 1997; 65(2):83-90. PubMed ID: 9253032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.